GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Inventories, Finished Goods

Medexus Pharmaceuticals (FRA:P731) Inventories, Finished Goods : €0.0 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Inventories, Finished Goods?

Medexus Pharmaceuticals's annual finished goods increased from Mar. 2022 (€12.4 Mil) to Mar. 2023 (€13.9 Mil) and increased from Mar. 2023 (€13.9 Mil) to Mar. 2024 (€16.1 Mil).


Medexus Pharmaceuticals Inventories, Finished Goods Historical Data

The historical data trend for Medexus Pharmaceuticals's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Inventories, Finished Goods Chart

Medexus Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.25 8.78 12.38 13.88 16.11

Medexus Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16.11 - - -

Medexus Pharmaceuticals Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Medexus Pharmaceuticals Business Description

Traded in Other Exchanges
Address
10 King Street East, Suite 600, Toronto, ON, CAN, M5C 1C3
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.

Medexus Pharmaceuticals Headlines

No Headlines